
GSK-7975A
CAS No. 1253186-56-9
GSK-7975A( GSK-7975 | GSK7975 )
Catalog No. M11017 CAS No. 1253186-56-9
A selective CRAC channel blocker that inhibits store-operated Ca(2+) entry with IC50 of 3.4 uM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 87 | Get Quote |
![]() ![]() |
10MG | 140 | Get Quote |
![]() ![]() |
25MG | 302 | Get Quote |
![]() ![]() |
50MG | 488 | Get Quote |
![]() ![]() |
100MG | 696 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGSK-7975A
-
NoteResearch use only, not for human use.
-
Brief DescriptionA selective CRAC channel blocker that inhibits store-operated Ca(2+) entry with IC50 of 3.4 uM.
-
DescriptionA selective CRAC channel blocker that inhibits store-operated Ca(2+) entry with IC50 of 3.4 uM; shows little or no effect on the physiological Ca(2+) spiking evoked by acetylcholine or cholecystokinin; inhibits the release of mast cell mediators and T-cell cytokines from multiple human and rat preparations.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK-7975 | GSK7975
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1253186-56-9
-
Formula Weight397.305
-
Molecular FormulaC18H12F5N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 90 mg/mL 226.53 mM
-
SMILESO=C(NC1=NN(CC2=CC=C(O)C=C2C(F)(F)F)C=C1)C3=C(F)C=CC=C3F
-
Chemical Name2,6-difluoro-N-(1-(4-hydroxy-2-(trifluoromethyl)benzyl)-1H-pyrazol-3-yl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gerasimenko JV, et al. Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13186-91.
2. Rice LV, et al. Eur J Pharmacol. 2013 Mar 15;704(1-3):49-57.
3. Derler I, et al. Cell Calcium. 2013 Feb;53(2):139-51.
molnova catalog



related products
-
alpha-L-Rhamnose
Addition of the Rhamnose-rich polysaccharide RROP-1 to normal human dermal fibroblasts (NHDFs) and human endothelial cells produced a dose-dependent stimulation of the calcium-signaling pathway inducing fast and transient increases in Ca2 influx and intracellular free Ca2 level.
-
Nilvadipine
Nilvadipine is a calcium channel blocker (CCB) for treatment of hypertension.
-
Equilin
Equilin (7-Dehydroestrone) is a neurotrophic estrogenic steroid with vasodilatory activity that increases monocyte-endothelial adhesion through NF-κB signalling.